73 related articles for article (PubMed ID: 2952272)
1. PFK inhibition test for cancer detection: clinical applications and mechanisms of PFK inhibition.
Nakamura K; Kituta T; Nakamura Y; Nakajima Y; Kobayashi K; Uchida T
Cancer Detect Prev; 1987; 10(1-2):37-55. PubMed ID: 2952272
[TBL] [Abstract][Full Text] [Related]
2. Decrease of serum buffering capacity associated with malignant neoplasms.
Nakamura K; Nakajima Y; Nakamura Y; Ogiwara H; Koide A
Cancer Detect Prev; 1988; 13(3-4):175-87. PubMed ID: 2977297
[TBL] [Abstract][Full Text] [Related]
3. A new cancer marker: a possible cancer screening method based on the suppression of phosphofructokinase by sera from cancer patients.
Nakamura K; Kituta T; Takahashi T; Nakamura Y; Nakajima Y
Cancer Detect Prev; 1985; 8(1-2):207-18. PubMed ID: 2933146
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two similar differential tumor markers based on phosphofructokinase activity arising from the influence of cancer patient serum.
Nakamura K; Nakajima Y; Nakamura Y
Cancer Detect Prev; 1988; 13(3-4):239-50. PubMed ID: 2977298
[TBL] [Abstract][Full Text] [Related]
5. [Regulatory mechanism of phosphofructokinase in rabbit dental pulp].
Negishi T
Nichidai Koko Kagaku; 1990 Mar; 16(1):37-43. PubMed ID: 2152004
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy.
Vora S; Halper JP; Knowles DM
Cancer Res; 1985 Jul; 45(7):2993-3001. PubMed ID: 3159473
[TBL] [Abstract][Full Text] [Related]
7. Purification, molecular and kinetic characterization of phosphofructokinase-1 from the yeast Schizosaccharomyces pombe: evidence for an unusual subunit composition.
Reuter R; Naumann M; Bär J; Haferburg D; Kopperschläger G
Yeast; 2000 Oct; 16(14):1273-85. PubMed ID: 11015725
[TBL] [Abstract][Full Text] [Related]
8. Properties of rat lens phosphofructokinase.
Cheng HM; Chylack LT
Invest Ophthalmol; 1976 Apr; 15(4):279-87. PubMed ID: 4411
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of 6-phosphofructo-2-kinase from Saccharomyces cerevisiae: inhibition of the enzyme by ATP.
Bedri A; Kretschmer M; Schellenberger W; Hofmann E
Biomed Biochim Acta; 1989; 48(7):403-11. PubMed ID: 2529854
[TBL] [Abstract][Full Text] [Related]
10. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
Pislarasu M; Oproiu A; Taranu D; Herberman RB; Sulica A
Cancer Res; 1988 May; 48(9):2596-603. PubMed ID: 3356020
[TBL] [Abstract][Full Text] [Related]
11. Suppression of glucose utilization of murine peritoneal exudate macrophages by body fluids from cancer patients and identification of the susceptible enzyme.
Nakamura K; Nakajima Y; Nakamura Y
J Natl Cancer Inst; 1986 Nov; 77(5):1035-8. PubMed ID: 2945958
[TBL] [Abstract][Full Text] [Related]
12. Phosphofructokinase of calf trabecular meshwork.
Anderson PJ; Karageuzian LN; Epstein DL
Invest Ophthalmol Vis Sci; 1984 Nov; 25(11):1262-6. PubMed ID: 6238014
[TBL] [Abstract][Full Text] [Related]
13. Fructose-2,6-bisphosphate counteracts guanidinium chloride-, thermal-, and ATP-induced dissociation of skeletal muscle key glycolytic enzyme 6-phosphofructo-1-kinase: A structural mechanism for PFK allosteric regulation.
Zancan P; Almeida FV; Faber-Barata J; Dellias JM; Sola-Penna M
Arch Biochem Biophys; 2007 Nov; 467(2):275-82. PubMed ID: 17923106
[TBL] [Abstract][Full Text] [Related]
14. Phosphofructokinase in rabbit dental pulp is less sensitive to ATP inhibition.
Yamazaki T; Hara M; Kurihara Y; Kodaka S; Nakai K; Ozaki I; Sugiya H; Furuyama S
J Nihon Univ Sch Dent; 1989 Mar; 31(1):366-71. PubMed ID: 2525180
[TBL] [Abstract][Full Text] [Related]
15. Regulatory properties of 6-phosphofructokinase and control of glycolysis in boar spermatozoa.
Kamp G; Schmidt H; Stypa H; Feiden S; Mahling C; Wegener G
Reproduction; 2007 Jan; 133(1):29-40. PubMed ID: 17244730
[TBL] [Abstract][Full Text] [Related]
16. Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat.
Oskam R; Rijksen G; Staal GE; Vora S
Cancer Res; 1985 Jan; 45(1):135-42. PubMed ID: 3155492
[TBL] [Abstract][Full Text] [Related]
17. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
18. [Suppression of phosphofructokinase (PFK) by sera from cancer patients, and mechanism of the antagonistic effect of PSK].
Nakamura K; Nakajima Y; Nomoto K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):970-6. PubMed ID: 2938549
[TBL] [Abstract][Full Text] [Related]
19. pH-dependent temperature sensitivity of rat lens phosphofructokinase.
Cheng HM; Chylack LT
Invest Ophthalmol; 1976 Jun; 15(6):505-9. PubMed ID: 6404
[TBL] [Abstract][Full Text] [Related]
20. ATP and fructose-2,6-bisphosphate regulate skeletal muscle 6-phosphofructo-1-kinase by altering its quaternary structure.
Zancan P; Marinho-Carvalho MM; Faber-Barata J; Dellias JM; Sola-Penna M
IUBMB Life; 2008 Aug; 60(8):526-33. PubMed ID: 18465796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
